<DOC>
	<DOCNO>NCT02355236</DOCNO>
	<brief_summary>Naxozol combination product naproxen , non-steroidal anti-inflammatory drug ( NSAID ) esomeprazole , proton pump inhibitor design improve symptom reduce risk gastric ulcer patient risk develop NSAID-associated gastric ulcer treatment osteoarthritis , rheumatoid arthritis , ankylose spondylitis . The purpose study investigate whether naxozol protects gastrointestinal tract effectively compare celecoxib , COX-2 inhibitor .</brief_summary>
	<brief_title>Gastro-protective Effect Pain Relief Effect Naxozol Compared Celecoxib Patients With Osteoarthritis</brief_title>
	<detailed_description>A total 10 orthopedic investigator participate study . The effectiveness gastro-protection study drug assess Leeds Dyspepsia Questionnaire ( LDQ ) . The orthopedic investigator train questionnaire administration expert gastroenterologist prior start study .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Koreans give informed consent Patients ability read comprehension complete questionnaire ( EQ5D VAS ) willingness followup 12 week Patients osteoarthritis symptom confirm his/her medical history painVAS 40 Patients participate interventional study participate within 30 day screen Alcohol drug abuse within 6 month alcohol consumption 21 unit week Peptic ulcer accompany complication bleeding , perforation , penetration gastric outlet obstruction within 5 year , history active peptic ulcer peptic ulcer without complication within 6 month screen Patients know Helicobacter pylori infection receive bacteriostatic treatment Known gastroesophageal reflux disease ( GERD ) Any follow joint disease may significant effect efficacy safety assessment : septic arthritis , inflammatory joint arthritis rheumatoid arthritis , gout , recurrent pseudopain , Paget 's disease , joint fracture , joint ochronosis , acromegaly , hematochromatosis , Wilson 's disease , primary osteochondrosis , Ehlers Danlos Syndrome , collagen genetic disorder Patients schedule admission hospital elective surgery study History gastrointestinal cancer Gastrointestinal disorder related drug malabsorption Gastrointestinal bleeding , cerebral bleeding , bleed disorder , severe hematological disorder Clinically significant disease moderate severe liver disease ( Child Pough Class II ) , severe heart failure history coronary artery bypass graft ( CABG ) , severe kidney disease ( CrCl &lt; 30ml/min ) Know allergy experience ingredient study drug NASIDs protocol pump inhibitor ( PPIs ) Patients joint surgery osteoarthritis within 1 year Women childbearing potential agree clinically appropriate contraception study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Naxozol</keyword>
	<keyword>LDQ</keyword>
	<keyword>GSRS</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Gastroprotective</keyword>
</DOC>